Cargando…
Recent Advances in the Delivery Carriers and Chemical Conjugation Strategies for Nucleic Acid Drugs
SIMPLE SUMMARY: In recent years, nucleic acid drugs, such as antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), have attracted attention as a new modality for cancer treatment. In this review, we introduce and discuss an overview of various drug delivery systems (DDSs) and ligand...
Autores principales: | Oyama, Shota, Yamamoto, Tsuyoshi, Yamayoshi, Asako |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345803/ https://www.ncbi.nlm.nih.gov/pubmed/34359781 http://dx.doi.org/10.3390/cancers13153881 |
Ejemplares similares
-
Recent Advancements in Development and Therapeutic Applications of Genome-Targeting Triplex-Forming Oligonucleotides and Peptide Nucleic Acids
por: Mikame, Yu, et al.
Publicado: (2023) -
Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs
por: Fumoto, Shintaro, et al.
Publicado: (2021) -
Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides
por: Wada, Fumito, et al.
Publicado: (2021) -
Framework nucleic acids as programmable carrier for transdermal drug delivery
por: Wiraja, Christian, et al.
Publicado: (2019) -
Recent Advances in Chemical Modification of Peptide Nucleic Acids
por: Rozners, Eriks
Publicado: (2012)